
No. of Pages: 113 | Report Code: BMIRE00029223 | Category: Life Sciences
No. of Pages: 113 | Report Code: BMIRE00029223 | Category: Life Sciences
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2.1 Key Insights
2.2 Europe Acute Pancreatitis Market, by Country (US$ Million)
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
5.1 Key Market Drivers
5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:
6.1 Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
7.1 Overview
7.2 Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
7.3.1 Overview
7.3.2 Medications: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Europe Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)
7.4 Diagnosis
7.4.1 Overview
7.4.2 Diagnosis: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Europe Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.1 Overview
8.2 Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
8.3.1 Overview
8.3.2 Gallstones: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
8.4.1 Overview
8.4.2 Alcoholism: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
8.5.1 Overview
8.5.2 Genetic Disorders: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
8.6.1 Overview
8.6.2 Infections: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.1 Overview
9.2 Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
10.1 Overview
10.1.1.1 Europe Acute Pancreatitis Market, by Country
10.1.1.2 UK
10.1.1.2.1 Overview
10.1.1.2.2 UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 UK: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.1 UK: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.2 UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.2.4 UK: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.2.5 UK: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Germany
10.1.1.3.1 Overview
10.1.1.3.2 Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Germany: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.1 Germany: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.2 Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.3.4 Germany: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.3.5 Germany: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.4 France
10.1.1.4.1 Overview
10.1.1.4.2 France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 France: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.1 France: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.2 France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.4.4 France: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.4.5 France: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.5 Italy
10.1.1.5.1 Overview
10.1.1.5.2 Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Italy: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.5.3.1 Italy: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.5.3.2 Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.5.4 Italy: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.5.5 Italy: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.6 Spain
10.1.1.6.1 Overview
10.1.1.6.2 Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 Spain: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.6.3.1 Spain: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.6.3.2 Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.6.4 Spain: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.6.5 Spain: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.7 Nordic Region
10.1.1.7.1 Overview
10.1.1.7.2 Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Nordic Region: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.7.3.1 Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.7.3.2 Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.7.4 Nordic Region: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.7.5 Nordic Region: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.8 Netherlands
10.1.1.8.1 Overview
10.1.1.8.2 Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.8.3 Netherlands: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.8.3.1 Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.8.3.2 Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.8.4 Netherlands: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.8.5 Netherlands: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.9 Rest of Europe
10.1.1.9.1 Overview
10.1.1.9.2 Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.9.3 Rest of Europe: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.9.3.1 Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.9.3.2 Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.9.4 Rest of Europe: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.9.5 Rest of Europe: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
11.1 Overview
11.2 Growth Strategies in the Europe Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Samsung Healthcare
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Baxter International Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Dynavax Technologies Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Actim Oy
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Medtronic Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Boston Scientific Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Fresenius Kabi AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13.1 About Us
13.2 Glossary of Terms
Table 1. Europe Acute Pancreatitis Market Segmentation
Table 2. Europe Acute Pancreatitis Market, by Medications – Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Acute Pancreatitis Market, by Diagnosis – Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 6. UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 7. UK: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 8. UK: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. France: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 15. France: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 17. France: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 18. France: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 29. Nordic Region: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 30. Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 31. Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 32. Nordic Region: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 33. Nordic Region: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 34. Netherlands: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 35. Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 36. Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 37. Netherlands: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 38. Netherlands: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 39. Rest of Europe: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 40. Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 41. Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 42. Rest of Europe: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 44. Recent Inorganic Growth Strategies in the Europe Acute Pancreatitis Market
Table 45. Recent Organic Growth Strategies in the Europe Acute Pancreatitis Market
Table 46. Glossary of Terms, Europe Acute Pancreatitis Market
Figure 1. Europe Acute Pancreatitis Market Segmentation, By Country
Figure 2. Europe Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Acute Pancreatitis Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 21. Europe Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies in the Europe Acute Pancreatitis Market